$EHTH

EHTH Q2'26 Earnings: revenue estimate is 33.28M USD

eHealth, Inc. (EHTH) is scheduled to report Q2 2026 earnings on Aug. 4 after market close, with results expected at 4:00 PM ET. The article cites a Q2 2026 revenue estimate of $33.28 million and an EPS estimate of -$0.84.

Original reporting
Published Jul 28, 2026, 11:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
EHTH Q2'26 Earnings: revenue estimate is 33.28M USD — source image
Decision brief

The 30-second read

$EHTHNeutralLow
01

Why it matters

The only actionable elements are the scheduled release time and the stated consensus revenue and EPS expectations; there is no new fundamental disclosure beyond estimates.

02

Market read

Traders can use the consensus numbers and timing to frame expectations for the Aug 4 after-hours earnings reaction.

03

What to watch

The article does not mention guidance changes, backlog, payer mix, or any operational drivers that could explain upside or downside versus the $33.28M and -$0.84 expectations.

Relevance 4/10Novelty 3/10Timing: ahead of Aug 4 after-hours Q2'26 earnings release (4:00 PM ET)

Background

The piece is a tradingview-style earnings calendar preview for eHealth, Inc. ahead of its Q2'26 report.

Company-level read

Ticker impact

$EHTHNeutralMedium confidence
Context

Article says eHealth, Inc. (EHTH) will report Q2'26 results Aug 4 after the close, with consensus revenue of $33.28M and EPS of -$0.84.

Expected impact

Likely limited immediate impact; the main trading driver will be the actual Aug 4 results versus these estimates.

Evidence & confidence

The text provides expected revenue and EPS plus the after-hours timing, but contains no new company-specific guidance, filings, or surprises.

Market effects

Minimal, as it provides only a single-company earnings preview without broader sector signals.

None indicated.

None indicated.

Counterpoint

Consensus estimates can be stale; traders may treat this as low-signal and focus on any late-breaking revisions or management commentary not included here.

Key entities

  • EHTH

    eHealth, Inc., scheduled to announce Q2'26 results on Aug 4 after the market closes.

Related articles

$EHTHMed

eHealth, Inc. (EHTH): Results of Operations and Financial Condition

eHealth, Inc. (EHTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. eHealth, Inc. Announces Second Quarter 2026 Results Lifetime Advisory Model increasing member engagement On track to achieve meaningful YoY improvements in annual operating cash flow INDIANAPOLIS — August 4, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health ins

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.